Huntsville, Alabama — According to state and local development sources, Glaukos plans to invest $80 Million to build out 200,000 square feet of new space in Huntsville. The company plans to occupy the new space at Cummings Research Park in Huntsville, on or about May 1, 2027. According to the company website At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

To learn more about Glaukos, visit https://www.glaukos.com/

Company Contact:
Thomas Burns, Chief Executive Officer
949-367-9600

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.